Delivery Order SPE2DB20D3505-SPE2DB24FU6P7
Award Date
7/22/24
Potential Completion Date
7/23/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,534.29 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of March 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,108.58 firm fixed price delivery order is for the procurement of Cyclosporine 0.05% eye emulsion, with a completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,784.10 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty medication. The contract has a completion date of July 5, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $3,650.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Cyclosporine 0.05% Eye Emulsion, with an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,333.59 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical medication used in the treatment of various eye conditions. The contract has a period of performance through June 8, 2023 and does not have a set-aside designation, indicating open competition....
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $9,858.80. The contract is for the delivery of cyclosporine 0.05% eye emulsion, a pharmaceutical product used in the treatment of eye conditions. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.52 Firm Fixed Price Delivery Order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product, with a period of performance through March 17, 2025. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to support military healthcare programs. The $3,065.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,279.87, is a delivery order for the supply of cyclosporine 0.05% eye emulsion. The contract has an ultimate completion date of May 30, 2023 and is a firm fixed-price, non-set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $9,748.14 and is for the delivery of cyclosporine 0.05% eye emulsion. The contract is a Firm Fixed Price Delivery Order with a completion date of January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...